Associations between TS, TTF-1, FR-α, FPGS, and Overall Survival in Patients with Advanced Non–Small-Cell Lung Cancer Receiving Pemetrexed Plus Carboplatin or Gemcitabine Plus Carboplatin as First-Line Chemotherapy

JOURNAL ARTICLE published October 2013 in Journal of Thoracic Oncology

Authors: Bjørn H. Grønberg | Marius Lund-Iversen | Erik H. Strøm | Odd Terje Brustugun | Helge Scott